Table 2.
Factors | Patient number | Median DFS (months) | P (log-rank test) |
---|---|---|---|
Adjuvant chemotherapy | |||
FU/LV | 19 | 14.2 | 0.022 |
FOLFOX/FOLFIRI | 31 | 34.3 | |
Age (years) | |||
<70 | 26 | 20.1 | 0.391 |
≥70 | 24 | 15.3 | |
Gender | |||
Male | 34 | 18.9 | 0.647 |
Female | 16 | 17.0 | |
Primary tumor | |||
Colon | 34 | 18.9 | 0.768 |
Rectum | 16 | 15.4 | |
Stage of primary CRC | |||
II | 19 | Not achieved (>33.0) | 0.016 |
III | 31 | 13.6 | |
Maximum CLM size (cm) | |||
≤3 | 30 | 13.6 | 0.693 |
>3 | 20 | 33.0 | |
Number of CLMs | |||
1 | 29 | 33.0 | 0.221 |
≥2 | 21 | 17.0 | |
CLM distribution | |||
Unilobar | 40 | 33.0 | 0.335 |
Bilobar | 10 | 15.3 | |
Time from surgery of primary CRC to metastases (months) | |||
≤12 | 24 | 11.8 | 0.036 |
>12 | 26 | 34.3 | |
CLM resection margin | |||
R0 resection | 46 | 33.0 | 0.00 |
R1 resection | 4 | 3.9 | |
CEA at metastasectomy (ng/ml) | |||
≤50 | 39 | 33.0 | 0.003 |
>50 | 11 | 9.0 | |
Prior FOLFOX/FOLFIRI following resection of primary CRC | |||
No | 46 | 17.0 | 0.730 |
Yes | 4 | 20.1 |